ASX News
Neurizon NUZ-001 OLE study demonstrates long-term safety, efficacy signals
HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.
Market Cap $1.824B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| DMP | On board the rocketship | 11:52 | 57 | 21K | |||
|
|||||||
| DMP | Ann: Change in substantial holding | 11/08/25 | 0 | 271 | |||
|
|||||||
| DMP | Ann: Becoming a substantial holder | 09/08/25 | 2 | 1.1K | |||
|
|||||||
| DMP | Why DMP price falling in ASX? Any reasons | 07/08/25 | 205 | 83K | |||
|
|||||||
| DMP | Ann: Response to ASX Appendix 3Y Query | 05/08/25 | 1 | 748 | |||
|
|||||||
| DMP | Ann: Executive Chair Investor Q&A | 27/07/25 | 74 | 23K | |||
|
|||||||
| DMP | Ann: Change of Director's Interest Notice | 25/07/25 | 0 | 436 | |||
|
|||||||
| DMP | Ann: Change in substantial holding | 08/07/25 | 0 | 451 | |||
|
|||||||
See All Discussions
Timeline
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
$19.32 |
Change
-0.340(1.73%) |
Mkt cap ! $1.824B | |||
| Open | High | Low | Value | Volume |
| $19.70 | $19.82 | $19.16 | $13.76M | 706.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 270 | $19.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.37 | 2307 | 1 |
View Market Depth
| Last trade - 16.10pm 22/08/2025 (20 minute delay) ? |
|
|||||
|
Last
$19.32 |
Change
-0.340 ( 1.72 %) |
||||
| Open | High | Low | Volume | ||
| $19.69 | $19.75 | $19.16 | 66369 | ||
| Last updated 15.59pm 22/08/2025 ? | |||||
| DMP (ASX) Chart |
